Tsung‐Hao Liu

1.5k total citations
31 papers, 1.2k citations indexed

About

Tsung‐Hao Liu is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Tsung‐Hao Liu has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Tsung‐Hao Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Tsung‐Hao Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Tsung‐Hao Liu collaborates with scholars based in Taiwan, Hong Kong and Denmark. Tsung‐Hao Liu's co-authors include Ann‐Lii Cheng, Pei‐Jer Chen, Kuen‐Feng Chen, Yu‐Yun Shao, Li‐Chun Lu, Chih‐Hung Hsu, Chiun Hsu, Tsanyao Frank Yang, Vivek Walia and Ching‐Chou Fu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Tsung‐Hao Liu

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsung‐Hao Liu Taiwan	17	447	398	279	185	165	31	1.2k
Keita Sakamoto Japan	16	255 0.6×	171 0.4×	75 0.3×	147 0.8×	127 0.8×	49	773
Rosemary Chester United Kingdom	6	385 0.9×	366 0.9×	39 0.1×	155 0.8×	267 1.6×	11	851
Robert Shumaker United States	17	462 1.0×	855 2.1×	196 0.7×	242 1.3×	419 2.5×	38	1.8k
Chien-Ying Wang Taiwan	23	520 1.2×	379 1.0×	45 0.2×	186 1.0×	214 1.3×	44	1.6k
Heinz Josef Lenz United States	19	542 1.2×	974 2.4×	93 0.3×	178 1.0×	425 2.6×	37	1.4k
Jianfei Fu China	18	311 0.7×	342 0.9×	16 0.1×	307 1.7×	112 0.7×	101	995
Yukio Koibuchi Japan	21	442 1.0×	351 0.9×	53 0.2×	269 1.5×	127 0.8×	132	1.5k
Satoshi Inagawa Japan	14	234 0.5×	377 0.9×	85 0.3×	146 0.8×	507 3.1×	53	1.1k
Sung‐Min Chun South Korea	25	692 1.5×	988 2.5×	49 0.2×	643 3.5×	572 3.5×	79	2.1k
Ran Wei China	15	130 0.3×	155 0.4×	34 0.1×	53 0.3×	112 0.7×	69	598

Countries citing papers authored by Tsung‐Hao Liu

Since Specialization

Citations

This map shows the geographic impact of Tsung‐Hao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Hao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Hao Liu more than expected).

Fields of papers citing papers by Tsung‐Hao Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Hao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Hao Liu. The network helps show where Tsung‐Hao Liu may publish in the future.

Co-authorship network of co-authors of Tsung‐Hao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Hao Liu. A scholar is included among the top collaborators of Tsung‐Hao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Hao Liu. Tsung‐Hao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Yu‐Yun, Tung‐Hung Su, Ming‐Chih Ho, et al.. (2025). Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial. British Journal of Cancer. 132(9). 822–827. 1 indexed citations

Liu, Tsung‐Hao, San‐Chi Chen, Kun‐Ming Rau, et al.. (2024). Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression. Liver Cancer. 13(5). 509–521. 7 indexed citations

Su, Yung‐Yeh, Jing‐Houng Wang, Hung‐Wei Wang, et al.. (2022). MO5-4 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors. Annals of Oncology. 33. S484–S484. 2 indexed citations

Liu, Tsung‐Hao, Ying‐Chun Shen, & Ann‐Lii Cheng. (2022). Immune checkpoint inhibitors for hepatocellular carcinoma – A game changer in treatment landscape. Journal of the Formosan Medical Association. 121(8). 1371–1383. 3 indexed citations

Chen, Bang‐Bin, Po‐Chin Liang, Tiffany Ting‐Fang Shih, et al.. (2022). Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma. European Radiology. 33(1). 512–522. 40 indexed citations

Shen, Ying‐Chun, Yung‐Ming Jeng, Chiun Hsu, et al.. (2021). Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy. Cancers. 13(20). 5142–5142. 3 indexed citations

Shen, Ying‐Chun, Pei‐Chang Lee, Yu‐Lun Kuo, et al.. (2021). An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 809–822. 26 indexed citations

Liu, Tsung‐Hao, Yu‐Yun Shao, & Chih‐Hung Hsu. (2020). It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade. Journal of the Formosan Medical Association. 120(1). 1–4. 7 indexed citations

Lee, Meng‐Rui, Kai‐Lun Yu, Tsung‐Hao Liu, et al.. (2019). Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study. Scientific Reports. 9(1). 9478–9478. 16 indexed citations

10.

Shao, Yu‐Yun, Tsung‐Hao Liu, Chiun Hsu, et al.. (2019). Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma. Liver International. 39(11). 2184–2189. 76 indexed citations

11.

Lu, Li‐Chun, Chiun Hsu, Yu‐Yun Shao, et al.. (2019). Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Liver Cancer. 8(6). 480–490. 62 indexed citations

12.

Liu, Tsung‐Hao, Chih‐Hung Hsu, & Yu‐Yun Shao. (2018). Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure. Liver Cancer. 7(2). 205–208. 3 indexed citations

13.

Lu, Li‐Chun, Yi‐Hsuan Lee, Chun‐Jung Chang, et al.. (2018). Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment. Liver Cancer. 8(2). 110–120. 44 indexed citations

14.

Shao, Yu‐Yun, et al.. (2016). Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 31(7). 1336–1341. 24 indexed citations

15.

Liao, Yiji, Fei-Meng Zheng, Wei‐Guo Zhu, et al.. (2011). EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene. 31(5). 583–594. 176 indexed citations

16.

Chen, Kuen‐Feng, Chun‐Yu Liu, Tsung‐Hao Liu, et al.. (2010). CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene. 29(47). 6257–6266. 136 indexed citations

17.

Chen, Kuen‐Feng, Huichuan Yu, Tsung‐Hao Liu, et al.. (2009). Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation. Journal of Hepatology. 52(1). 88–95. 67 indexed citations

18.

Yang, Tsanyao Frank, Vivek Walia, L. L. Chyi, et al.. (2005). Variations of soil radon and thoron concentrations in a fault zone and prospective earthquakes in SW Taiwan. Radiation Measurements. 40(2-6). 496–502. 140 indexed citations

19.

Chen, Yue‐Gau, et al.. (2003). Luminescence dating of neotectonic activity on the southwestern coastal plain, Taiwan. Quaternary Science Reviews. 22(10-13). 1223–1229. 20 indexed citations

20.

Tsai, Chu‐Lin, et al.. (1992). Estrogen and osteoarthritis: A study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees. Biochemical and Biophysical Research Communications. 183(3). 1287–1291. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact